BRIEF published on 07/29/2025 at 14:05, 4 months 6 days ago Ovation Science: Expanding Cannabis Topicals into Florida Market Planet 13 Holdings Invisicare Technology Florida Cannabis Market Ovation Science Transdermal Topicals
PRESS RELEASE published on 07/29/2025 at 14:00, 4 months 6 days ago Ovation Science Expands with Planet 13 into Florida Ovation Science expands license agreement with Planet 13 to bring Invisicare® topical cannabis products to Florida, leveraging Planet 13's extensive retail network License Agreement Planet 13 Ovation Science Florida Market Topical Products
BRIEF published on 12/04/2024 at 14:05, 1 year ago Ovation Science Expands Transdermal Cannabis Products to Pennsylvania US Expansion Invisicare Technology Ovation Science Transdermal Cannabis Pennsylvania Launch
PRESS RELEASE published on 12/04/2024 at 14:00, 1 year ago Ovation Science Licensee Launches Innovative Transdermal Cannabis Products in Pennsylvania Ovation Science Inc. announces official launch of transdermal cannabis products in Pennsylvania through licensee PA Options for Wellness Inc. using proprietary Invisicare® technology Ovation Science Inc. Invisicare® Technology Pennsylvania Launch Transdermal Cannabis Products PA Options For Wellness Inc.
BRIEF published on 04/30/2024 at 12:40, 1 year 7 months ago Ovation Science Launches Topicals with Planet 13 in Nevada Nevada Cannabis Market Planet 13 Invisicare Technology Ovation Science Cannabis Topicals
PRESS RELEASE published on 04/30/2024 at 12:35, 1 year 7 months ago Ovation Science Topicals Launch with Planet 13 in Nevada Ovation Science Inc. launches topical cannabis products in Nevada with Planet 13 Holdings, Inc., marking an exciting expansion of product offerings and leveraging patented skin delivery technology Invisicare® Planet 13 Holdings Inc. Ovation Science Inc. Topical Cannabis Products Nevada Launch Invisicare® Technology
BRIEF published on 04/11/2024 at 15:40, 1 year 7 months ago Ovation Science Expands Market Reach with Exclusive Canadian License Agreement Ovation Science Inc. Ripco Processing Canada Cannabis Market Invisicare Technology Cannabis Licensing Agreement
PRESS RELEASE published on 04/11/2024 at 15:35, 1 year 7 months ago Ovation Science Expands Market Reach with Exclusive Canadian License Agreement Ovation Science Inc. signs exclusive licensing agreement with Ripco for its topical cannabis products in Canada, expanding market presence with Invisicare® technology Ovation Science Inc. Ripco Processing Inc. Topical Cannabis Products Exclusive Licensing Agreement Invisicare
Published on 12/05/2025 at 02:35, 7 hours 26 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 9 hours 1 minute ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 56 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 1 minute ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 21 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 31 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 56 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour 16 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 17 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
